Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Current treatments and trials in malignant pleural mesothelioma.

Bibby AC, Maskell NA.

Clin Respir J. 2018 Jul;12(7):2161-2169. doi: 10.1111/crj.12938. Review.

PMID:
30129116
2.

Quality of Life Following Stereotactic Body Radiotherapy Versus Three-Dimensional Conformal Radiotherapy for Vertebral Metastases: Secondary Analysis of an Exploratory Phase II Randomized Trial.

Sprave T, Verma V, Förster R, Schlampp I, Bruckner T, Bostel T, El Shafie RA, Nicolay NH, Debus J, Rief H.

Anticancer Res. 2018 Aug;38(8):4961-4968. doi: 10.21873/anticanres.12814.

PMID:
30061276
3.

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.

Tsao MN, Xu W, Wong RK, Lloyd N, Laperriere N, Sahgal A, Rakovitch E, Chow E.

Cochrane Database Syst Rev. 2018 Jan 25;1:CD003869. doi: 10.1002/14651858.CD003869.pub4. Review.

4.
5.

Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review.

Chen H, Senan S, Nossent EJ, Boldt RG, Warner A, Palma DA, Louie AV.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):622-631. doi: 10.1016/j.ijrobp.2017.03.010. Epub 2017 Mar 15. Review.

PMID:
28581404
6.

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.

Basch E, Pugh SL, Dueck AC, Mitchell SA, Berk L, Fogh S, Rogak LJ, Gatewood M, Reeve BB, Mendoza TR, O'Mara AM, Denicoff AM, Minasian LM, Bennett AV, Setser A, Schrag D, Roof K, Moore JK, Gergel T, Stephans K, Rimner A, DeNittis A, Bruner DW.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):409-418. doi: 10.1016/j.ijrobp.2017.02.002. Epub 2017 Feb 10.

7.

Positron emission tomography and computed tomographic imaging (PET/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: A systematic review and meta-analysis.

Hallqvist A, Alverbratt C, Strandell A, Samuelsson O, Björkander E, Liljegren A, Albertsson P.

Radiother Oncol. 2017 Apr;123(1):71-77. doi: 10.1016/j.radonc.2017.02.011. Epub 2017 Mar 8. Review.

PMID:
28284494
8.

The potential role of brachytherapy in the irradiation of patients with lung cancer: a systematic review.

Youroukou A, Gkiozos I, Kalaitzi Z, Tsalafoutas I, Papalla K, Charpidou A, Kouloulias V.

Clin Transl Oncol. 2017 Aug;19(8):945-950. doi: 10.1007/s12094-017-1635-0. Epub 2017 Mar 2. Review.

PMID:
28255649
9.

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.

Mulvenna P, Nankivell M, Barton R, Faivre-Finn C, Wilson P, McColl E, Moore B, Brisbane I, Ardron D, Holt T, Morgan S, Lee C, Waite K, Bayman N, Pugh C, Sydes B, Stephens R, Parmar MK, Langley RE.

Lancet. 2016 Oct 22;388(10055):2004-2014. doi: 10.1016/S0140-6736(16)30825-X. Epub 2016 Sep 4.

10.

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.

Clive AO, Taylor H, Dobson L, Wilson P, de Winton E, Panakis N, Pepperell J, Howell T, Stewart SA, Penz E, Jordan N, Morley AJ, Zahan-Evans N, Smith S, Batchelor TJP, Marchbank A, Bishop L, Ionescu AA, Bayne M, Cooper S, Kerry A, Jenkins P, Toy E, Vigneswaran V, Gildersleve J, Ahmed M, McDonald F, Button M, Lewanski C, Comins C, Dakshinamoorthy M, Lee YCG, Rahman NM, Maskell NA.

Lancet Oncol. 2016 Aug;17(8):1094-1104. doi: 10.1016/S1470-2045(16)30095-X. Epub 2016 Jun 23.

11.

Economic evaluation of single-fraction versus multiple-fraction palliative radiotherapy for painful bone metastases in breast, lung and prostate cancer.

Collinson L, Kvizhinadze G, Nair N, McLeod M, Blakely T.

J Med Imaging Radiat Oncol. 2016 Oct;60(5):650-660. doi: 10.1111/1754-9485.12467. Epub 2016 May 13.

PMID:
27174870
12.

Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review.

Chen H, Louie AV, Boldt RG, Rodrigues GB, Palma DA, Senan S.

Clin Lung Cancer. 2016 Sep;17(5):e141-e149. doi: 10.1016/j.cllc.2015.12.009. Epub 2015 Dec 22. Review.

PMID:
26791542
13.

Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.

Westhoff PG, de Graeff A, Monninkhof EM, Pomp J, van Vulpen M, Leer JW, Marijnen CA, van der Linden YM; Dutch Bone Metastasis Study Group.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):694-701. doi: 10.1016/j.ijrobp.2015.06.024. Epub 2015 Jun 20.

PMID:
26281825
14.

Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: a multi-institutional phase II randomised clinical trial.

Pollock S, O'Brien R, Makhija K, Hegi-Johnson F, Ludbrook J, Rezo A, Tse R, Eade T, Yeghiaian-Alvandi R, Gebski V, Keall PJ.

BMC Cancer. 2015 Jul 18;15:526. doi: 10.1186/s12885-015-1483-7.

15.

The International Atomic Energy Agency (IAEA) randomized trial of palliative treatment of incurable locally advanced non small cell lung cancer (NSCLC) using radiotherapy (RT) and chemotherapy (CHT) in limited resource setting.

Jeremic B, Fidarova E, Sharma V, Faheem M, Ameira AA, Nasr Ben Ammar C, Frobe A, Lau F, Brincat S, Jones G.

Radiother Oncol. 2015 Jul;116(1):21-6. doi: 10.1016/j.radonc.2015.06.017. Epub 2015 Jul 7.

PMID:
26163093
16.

Response to "A meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer".

Ma JT, Han CB, Zheng JH, Guo QY.

Cancer Sci. 2015 Jun;106(6):783. doi: 10.1111/cas.12660. No abstract available.

17.

Meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer.

Vlayen J, Belderbos J, Widder J.

Cancer Sci. 2015 Jun;106(6):782. doi: 10.1111/cas.12659. No abstract available.

18.

Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.

Stevens R, Macbeth F, Toy E, Coles B, Lester JF.

Cochrane Database Syst Rev. 2015 Jan 14;1:CD002143. doi: 10.1002/14651858.CD002143.pub4. Review.

PMID:
25586198
19.

Local treatments for metastases of renal cell carcinoma: a systematic review.

Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TB, Canfield SE, Staehler M, Powles T, Ljungberg B, Bex A.

Lancet Oncol. 2014 Nov;15(12):e549-61. doi: 10.1016/S1470-2045(14)70235-9. Epub 2014 Oct 26. Review.

PMID:
25439697
20.

An easy tool to predict survival in patients receiving radiation therapy for painful bone metastases.

Westhoff PG, de Graeff A, Monninkhof EM, Bollen L, Dijkstra SP, van der Steen-Banasik EM, van Vulpen M, Leer JW, Marijnen CA, van der Linden YM; Dutch Bone Metastasis Study Group.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):739-47. doi: 10.1016/j.ijrobp.2014.07.051. Epub 2014 Sep 24.

PMID:
25260489

Supplemental Content

Loading ...
Support Center